The Seena Magowitz Foundation strives to advance awareness of pancreatic cancer, to educate pancreatic cancer patients, and to fund pancreatic cancer research.
A historic moment at #ASCO26: more than 9,000 oncologists rose for three standing ovations as Brian Wolpin, MD, MPH, Director of the Hale Family Center for Pancreatic Cancer Research, presented promising new Phase 3 results for an investigational treatment for metastatic pancreatic cancer.
In the trial, daraxonrasib helped patients with previously treated metastatic pancreatic cancer live significantly longer than those who received chemotherapy.
While more work remains, these findings offer something powerful: hope for patients and families facing one of the most challenging cancers.
As Dr. Wolpin said, “It is exciting to see that we may soon be able to help patients with metastatic pancreatic cancer in ways we haven’t been able to before, improving both survival and quality of life.”
Congratulations to the researchers and patients who made this important progress possible. 👏👏👏
Video Courtesy: @asco
CEO and Director W. Kimryn Rathmell, MD, PhD, and her @OhioState oncology team have brought Buckeye Nation to #ASCO26.
We’re proud to represent The James at the @ASCO Annual Meeting, where our experts are sharing info and insights from our work to create a cancer-free world.